Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine

BACKGROUND: Second generation antipsychotics (SGAs) are currently the most prescribed drugs in the treatment of schizophrenia. Despite their advantages, which include greater improvement in negative symptoms, cognitive function, prevention of deterioration, quality of life, and fewer extrapyramidal...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Ünsal, Cüneyt, Albayrak, Yakup, Albayrak, Neslihan, Kuloglu, Murat, Hashimoto, Kenji
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove Medical Press 2013
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3798239/
https://ncbi.nlm.nih.gov/pubmed/24143103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S52463
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia